Jomlal is launching a new Ebola treatment, and its CEO is making $ 1 million.
Joomla said Wednesday it’s also launching a $1.5 million treatment, which is designed to help the company’s employees stay fit.
“We are excited to have Jomlamas team involved in the new Jomlanas treatment,” Jomlahas CEO Paul J. Chiang said in a statement.
“This will be the largest Ebola treatment in history.
Jomlinas team is an industry leader in the field of drug development, and we’re looking forward to a great collaboration with them.”
The drug is a combination of a protein, called CAR-T, that is made by a patient’s immune system, and a peptide called CARV-T that the body uses to combat infection.
The new treatment is expected to cost $25,000, and will help people stay alive longer.
Jomlala also has a small business in Liberia, which it hopes will help boost the local economy.
“For us, it’s not about profit, it is about building a new economy,” Chiang told reporters Wednesday.
The company said its clinical trials will run from March to July.